as on October 16, 2025 at 1:29 am IST
Day's Low
Day's High
0.67%
Downside
4.83%
Upside
52 Week's Low
52 Week's High
43.77%
Downside
29.63%
Upside
Check Novavax, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
2.6155
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.38%
PE Ratio (TTM)
4.01
Industry PE ratio
-0.32286624203821657
PEG Ratio
0EBITDA
407.5M
Revenue (TTM)
1.1B
Profit Margin
39.20%
Return On Equity TTM
-898.20%
Track how Novavax, Inc. P/E has moved over time to understand its valuation trends.
Novavax, Inc. in the last 5 years
Lowest (-21.52x)
March 31, 2021
Industry (-0.32x)
October 16, 2025
Today (4.01x)
October 16, 2025
Highest (3.13x)
March 31, 2025
Today’s Price to Earnings Ratio: 4.01x
Compare market cap, revenue, PE, and other key metrics of Novavax, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.4B | -91.68% | 4.01 | 39.20% | |
BUY | $61.5B | 223.43% | -505.15 | -12.96% | |
NA | $37.1B | NA | NA | -3.89% | |
BUY | $105.7B | 87.04% | 28.99 | 31.86% | |
BUY | $59.6B | -3.89% | 14.07 | 31.37% |
The Novavax, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Novavax, Inc. investment value today
Current value as on today
₹92,615
Returns
Returns from Novavax, Inc. Stock
Dollar Returns*
₹4,831 (+4.83%)
Based on 12 analysts
66.67%
Buy
16.67%
Hold
16.67%
Sell
Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Novavax, Inc.. Average target price of $12.5
Get share price movements and forecasts by analysts on Novavax, Inc..
What analysts predicted
28.72%UPSIDE
Target Price
$12.5
Current Price
$8.91
Analyzed by
12 Analysts
Target
$12.50
Novavax, Inc. target price $12.5, a slight upside of 28.72% compared to current price of $8.91. According to 12 analysts rating.
Investment in Novavax, Inc. Shares on INDmoney has grown by 13.43% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:13.43% versus previous 30 day period
Search interest for Novavax, Inc. Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:14% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 14 October
Tue, 04:45 PM
-Novavax shares fall 1.3% as investor urges sale due to poor COVID vaccine rollout.
Tue, 08:02 PM
-Shares of Novavax rise 2.3% after investor suggests sale to larger pharma firm.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, NVAX stock has moved up by 3.5%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 56.2% return, outperforming this stock by 68.6%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 153.0% return, outperforming this stock by 207.8%
Profit Down
Netprofit is down for the last 2 quarters, 518.64M → 106.50M (in $), with an average decrease of 79.5% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 666.65M → 239.24M (in $), with an average decrease of 64.1% per quarter
Organisation | Novavax, Inc. |
Headquarters | 700 Quince Orchard Road, Gaithersburg, MD, United States, 20878 |
Industry | Health Technology |
CEO | Mr. John Charles Jacobs M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. James Patrick Kelly C.F.A. | Executive VP, CFO & Treasurer |
Mr. Mark J. Casey Esq. | Executive VP, Chief Legal Officer & Corporate Secretary |
Ms. Elaine O'Hara | Executive VP & Chief Strategy Officer |
Mr. Troy Morgan Esq., J.D. | Senior VP, Deputy General Counsel & Chief Compliance Officer |
Ms. Silvia Taylor M.B.A. | Executive VP and Chief Corporate Affairs & Advocacy Officer |
Dr. Henrietta Ukwu FACP FRAPS, M.D. | Executive VP & Chief Regulatory Officer |
Mr. John Charles Jacobs M.B.A. | President, CEO & Director |
Mr. Richard P. Crowley | Executive VP & COO |
Ms. Erika S. Trahan | Associate Director of Investor & Public Relations |
Mr. Ian J. Watkins | Executive VP & Chief Human Resources Officer |
Novavax, Inc. share price today is $8.91 as on at the close of the market. Novavax, Inc. share today touched a day high of $9.34 and a low of $8.85.
Novavax, Inc. share touched a 52 week high of $11.55 on and a 52 week low of $5.01 on . Novavax, Inc. stock price today i.e. is closed at $8.91,which is 22.86% down from its 52 week high and 77.84% up from its 52 week low.
Novavax, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Novavax, Inc. (NVAX) shares with as little as ₹87.985 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.85 in Novavax, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Novavax, Inc. share’s latest price of $8.91 as on October 16, 2025 at 1:29 am IST, you will get 1.1223 shares of Novavax, Inc.. Learn more about
fractional shares .
Novavax, Inc. stock has given -91.68% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?